GAG
GM Advisory Group’s Eli Lilly LLY Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $9.92M | Buy |
12,730
+792
| +7% | +$617K | 0.49% | 43 |
|
2025
Q1 | $9.86M | Buy |
11,938
+552
| +5% | +$456K | 0.53% | 35 |
|
2024
Q4 | $8.79M | Buy |
11,386
+397
| +4% | +$306K | 0.49% | 42 |
|
2024
Q3 | $9.74M | Buy |
10,989
+284
| +3% | +$252K | 0.58% | 34 |
|
2024
Q2 | $9.69M | Buy |
10,705
+89
| +0.8% | +$80.6K | 0.63% | 34 |
|
2024
Q1 | $8.26M | Buy |
10,616
+448
| +4% | +$349K | 0.58% | 33 |
|
2023
Q4 | $5.93M | Sell |
10,168
-361
| -3% | -$210K | 0.45% | 37 |
|
2023
Q3 | $5.66M | Sell |
10,529
-440
| -4% | -$236K | 0.46% | 32 |
|
2023
Q2 | $5.14M | Sell |
10,969
-1,374
| -11% | -$644K | 0.43% | 33 |
|
2023
Q1 | $4.24M | Buy |
12,343
+1,107
| +10% | +$380K | 0.39% | 37 |
|
2022
Q4 | $4.11M | Hold |
11,236
| – | – | 0.44% | 31 |
|
2022
Q3 | $3.63M | Hold |
11,236
| – | – | 0.46% | 25 |
|
2022
Q2 | $3.64M | Buy |
11,236
+1,507
| +15% | +$489K | 0.57% | 30 |
|
2022
Q1 | $2.79M | Sell |
9,729
-362
| -4% | -$104K | 0.33% | 48 |
|
2021
Q4 | $2.79M | Buy |
10,091
+244
| +2% | +$67.4K | 0.25% | 57 |
|
2021
Q3 | $2.28M | Sell |
9,847
-550
| -5% | -$127K | 0.23% | 56 |
|
2021
Q2 | $2.39M | Sell |
10,397
-948
| -8% | -$218K | 0.24% | 58 |
|
2021
Q1 | $2.12M | Sell |
11,345
-571
| -5% | -$107K | 0.25% | 54 |
|
2020
Q4 | $2.01M | Buy |
11,916
+1,733
| +17% | +$293K | 0.27% | 47 |
|
2020
Q3 | $1.51M | Hold |
10,183
| – | – | 0.23% | 52 |
|
2020
Q2 | $1.67M | Sell |
10,183
-4,117
| -29% | -$676K | 0.31% | 49 |
|
2020
Q1 | $1.98M | Buy |
+14,300
| New | +$1.98M | 0.54% | 32 |
|